Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Phase II Study of PHA-739358 in Patients With Multiple Myeloma Harbouring the t(4;14) Translocation With or Without FGFR3 Expression

NCT00872300 is registered in ClinicalTrials.gov with Nerviano Medical Sciences as lead sponsor.

NCT NCT00872300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00872300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Phase II Study of PHA-739358 in Patients With Multiple Myeloma Harbouring the t(4;14) Translocation With or Without FGFR3 Expression
Lead sponsor
Nerviano Medical Sciences
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2008
Completion date
September 30, 2010
Enrollment
7 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma